1970
DOI: 10.1159/000230260
|View full text |Cite
|
Sign up to set email alerts
|

Inhibition of Allergic Reactions in Man and Other Species by Cromoglycate

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3

Citation Types

4
39
0

Year Published

1971
1971
1985
1985

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 110 publications
(43 citation statements)
references
References 5 publications
4
39
0
Order By: Relevance
“…This effect appears to be similar to that produced by cromoglycate when used for bronchial asthma in man. However, pretreatment with cromoglycate aerosols, with concentrations as high as 100 mg/ml, did not significantly delay the onset of antigen-induced bronchoconstriction (unpublished observations); this is in accord with the observation of Assem & Mongar (1970) that cromoglycate is unable to prevent anaphylactic release of histamine from guinea-pig lungs. Our findings are not at variance with the idea that zinc may have acted through a different mechanism to stabilize the mast cell membrane.…”
supporting
confidence: 75%
“…This effect appears to be similar to that produced by cromoglycate when used for bronchial asthma in man. However, pretreatment with cromoglycate aerosols, with concentrations as high as 100 mg/ml, did not significantly delay the onset of antigen-induced bronchoconstriction (unpublished observations); this is in accord with the observation of Assem & Mongar (1970) that cromoglycate is unable to prevent anaphylactic release of histamine from guinea-pig lungs. Our findings are not at variance with the idea that zinc may have acted through a different mechanism to stabilize the mast cell membrane.…”
supporting
confidence: 75%
“…A similar lack of inhibitory effect of SCG on allergen challenge was found by Pearce et al (1974) using sensitised human skin in vitro. In the only published study to examine its in vivo effect in human skin, Assem & Mongar (1970) found SCG to be ineffective in one patient in whom mixtures of SCG and allergen were skin prick tested and in three other patients in whom PrausnitzKustner reactions were performed, although they used a narrower range of drug concentrations than we employed. One explanation for these results might be that mast cells in the skin are inaccessible to SCG, perhaps due to its lipid insolubility, but this hypothesis appears unlikely in view of the fact that in vitro studies reveal similar results (Pearce et al, 1974).…”
Section: Discussionmentioning
confidence: 89%
“…Furthermore, SCG is capable of inhibiting the PCA reaction in rat skin indicating that mast cells in this situation are accessible to the drug (Goose & Blair, 1969). SCG has been shown to inhibit mediator release from chopped human lung, but it has no significant effect on sensitized human leucocytes (Assem & Mongar, 1970). It may be that mast cells in the skin differ in some critical way from those in the lung.…”
Section: Discussionmentioning
confidence: 99%
“…Attempts to reproduce the inhibitory effect of SCG in antigen-induced anaphylactic models in guinea-pigs have met with mixed success. It has been suggested that anaphylactic reactions in animals mediated by the heat-labile mercaptoethanol-sensitive reagin type antibody are more readily inhibited by SCG than anaphylactic reactions mediated by non-reaginic antibodies (Cox, 1967;Lopez & Bloch, 1969;Assem & Mongar, 1970;Church, 1978). Lack of inhibition of guinea-pig PCA by SCG was reported by Cox (1967) and Martin (1971).…”
Section: Discussionmentioning
confidence: 99%